CORZ
Core Scientific, Inc.
Stock
$16.45+0.10 (+0.61%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $1.8B | $311M | $836M | $50M | $16M | $118M | — |
| Current assets | $2.4B | $896M | $904M | $97M | $85M | $757M | — |
| Goodwill | — | — | — | $0 | $0 | $1.1B | — |
| Intangible assets | $229M | $1.1M | — | $2.2M | $1.7M | $8.2M | — |
| Total assets | $5.3B | $2.3B | $1.5B | $712M | $808M | $2.4B | $15K |
| Current liabilities | $2.7B | $781M | $135M | $488M | $187M | $320M | $400 |
| Long-term debt | $4.3B | $1.1B | $1.1B | $684M | $0 | $652M | — |
| Total liabilities | $7.7B | $3.3B | $2.4B | $1.3B | $1.2B | $1.1B | $400 |
| Shareholders' equity | −$2.4B | −$963M | −$943M | −$597M | −$409M | $1.3B | $15K |
| Shares outstanding | 321.3M | — | 294.1M | 177.6M | 373.8M | 316.2M | — |
| Current ratio | 0.89 | 1.15 | 6.72 | 0.20 | 0.46 | 2.36 | — |